Mark Lotter

Mark Lotter

Chief Executive Officer at
Nuance Pharma (Shanghai) Co., Ltd.
64 year
Health Technology
Consumer Services

Profile

Mark Gavin Lotter was the founder of NovaMed Pharmaceuticals, Inc., founded in 2005, where the title held was President & Chief Executive Officer from 2006 to 2010.
Mr. Lotter is the founder of Nuance Pharma (Shanghai) Co., Ltd., founded in 2014, holding the title of Chief Executive Officer since 2014.
Former jobs include Director & CEO-China Operations at SciClone Pharmaceuticals LLC in 2012, Chief Executive Officer at Aspen Pharmacare Holdings Ltd., Independent Non-Executive Director at China Health Group, Inc. from 2015 to 2019, and Vice President-Operations at AstraZeneca Pharmaceuticals LP.
Education history includes undergraduate studies at the University of Natal and an MBA from the University of South Africa.

Mark Lotter active positions

CompaniesPositionStart
Chief Executive Officer 2014-08-11

Former positions of Mark Lotter

CompaniesPositionEnd
CHINA HEALTH GROUP INC. Director/Board Member 2019-06-19
SCICLONE PHARMACEUTICALS, INC. Director/Board Member 2012-12-13
Founder 2011-04-17
ASPEN PHARMACARE HOLDINGS LIMITED Chief Executive Officer -
Chief Operating Officer -
See the detail of Mark Lotter's experience

Training of Mark Lotter

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

31

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!